Jin Medical International Ltd. (ZJYL)
USD 0.84
(-5.65%)
USD 0.84
(-5.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.87 Million USD | 6.34% |
| 2022 | 2.7 Million USD | 2.84% |
| 2021 | 2.63 Million USD | 19.3% |
| 2020 | 2.2 Million USD | -39.52% |
| 2019 | 3.64 Million USD | -0.93% |
| 2018 | 3.68 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 897.04 Thousand USD | -19.32% |
| 2024 Q2 | 897.04 Thousand USD | 0.0% |
| 2023 Q4 | 1.11 Million USD | 100.0% |
| 2023 FY | 2.87 Million USD | 6.34% |
| 2023 Q1 | 883.17 Thousand USD | 19.29% |
| 2023 Q2 | 1.76 Million USD | 100.0% |
| 2023 Q3 | 555.94 Thousand USD | -68.53% |
| 2022 Q4 | 740.33 Thousand USD | 0.0% |
| 2022 Q3 | 740.33 Thousand USD | 20.79% |
| 2022 Q2 | 612.93 Thousand USD | 0.0% |
| 2022 Q1 | 612.93 Thousand USD | 55.04% |
| 2022 FY | 2.7 Million USD | 2.84% |
| 2021 Q4 | 395.33 Thousand USD | 0.0% |
| 2021 FY | 2.63 Million USD | 19.3% |
| 2021 Q3 | 395.33 Thousand USD | -57.05% |
| 2021 Q2 | 920.51 Thousand USD | 0.0% |
| 2021 Q1 | 920.51 Thousand USD | 77.88% |
| 2020 Q4 | 517.48 Thousand USD | 0.0% |
| 2020 FY | 2.2 Million USD | -39.52% |
| 2020 Q1 | 585.51 Thousand USD | -26.58% |
| 2020 Q2 | 585.51 Thousand USD | 0.0% |
| 2020 Q3 | 517.48 Thousand USD | -11.62% |
| 2019 Q1 | 1.02 Million USD | 0.0% |
| 2019 Q4 | 797.44 Thousand USD | 0.0% |
| 2019 Q2 | 1.02 Million USD | -0.0% |
| 2019 Q3 | 797.44 Thousand USD | -22.3% |
| 2019 FY | 3.64 Million USD | -0.93% |
| 2018 FY | 3.68 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 104.545% |
| AngioDynamics, Inc. | -184.34 Million USD | 101.561% |
| AtriCure, Inc. | -30.43 Million USD | 109.456% |
| Avinger, Inc. | -18.32 Million USD | 115.711% |
| Azenta, Inc. | -14.25 Million USD | 120.188% |
| BioLife Solutions, Inc. | -66.42 Million USD | 104.333% |
| The Cooper Companies, Inc. | 294.2 Million USD | 99.022% |
| Daxor Corporation | 280.64 Thousand USD | -925.595% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 118.938% |
| Femasys Inc. | -14.24 Million USD | 120.202% |
| GlucoTrack, Inc. | -7.09 Million USD | 140.556% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 184.282% |
| Hologic, Inc. | 789.5 Million USD | 99.635% |
| ICU Medical, Inc. | -29.65 Million USD | 109.706% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 99.84% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 120.946% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 90.439% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 143.194% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 143.194% |
| Masimo Corporation | 81.5 Million USD | 96.468% |
| Microbot Medical Inc. | -10.74 Million USD | 126.799% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 75.242% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 96.951% |
| Nephros, Inc. | -1.57 Million USD | 282.745% |
| NovoCure Limited | -207.04 Million USD | 101.39% |
| NEXGEL, Inc. | -3.15 Million USD | 191.17% |
| NEXGEL, Inc. | -3.15 Million USD | 191.17% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 103.035% |
| OraSure Technologies, Inc. | 53.65 Million USD | 94.636% |
| Pro-Dex, Inc. | 2.12 Million USD | -35.319% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 106.819% |
| Predictive Oncology Inc. | -13.98 Million USD | 120.582% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 197.522% |
| QuidelOrtho Corporation | -10.1 Million USD | 128.497% |
| Repligen Corporation | 41.57 Million USD | 93.077% |
| Sanara MedTech Inc. | -4.3 Million USD | 166.886% |
| STAAR Surgical Company | 21.34 Million USD | 86.517% |
| Sharps Technology, Inc. | -9.84 Million USD | 129.245% |
| Utah Medical Products, Inc. | 16.63 Million USD | 82.698% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 102.18% |